Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Home About Us My Account Personal Library Customer Service    
Welcome Guest
(login/register)
US: 800.298.5699
Int'l: +1.240.747.3093
Quick Search
Advanced Search >
Research Assistance
Send us a request >
Latest Research by Email
Receive email alerts of new market research reports in your industry.
Sign Up Today >
Home > Back to Category > Report Information Email a colleague | Printer format

U.S. Asthma/COPD Market

Frost & Sullivan
October 23, 2007
149 Pages - Pub ID: MC1596317
 
Questions about this report >
Order by fax >
XE.com
Abstract

Table of
Contents
Related Reports

Title
Published
Price
Snapshots US Pharmaceuticals 2009
By: Snapdata International Group
Snapdata's Snapshots US Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the US pharmaceutical market and  |  more...
Search inside this report
11/12/2009       $600.00
Pharmaceuticals Industry Report
By: Plimsoll Publishing Ltd.
The Global Pharmaceuticals Industry Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth financial  |  more...
11/1/2009       $1,500.00
Antipsychotics Market Forecast
By: Datamonitor
Introduction In 2008, seven major market sales of antipsychotics reached $18.2 billion. Datamonitor forecasts the market value to peak in 2011 when it will then succumb to generic erosion, particularly in the US where incursion is  |  more...
10/28/2009       $15,200.00
Commercial Insight: Antidiabetics in Australia - Reimbursement status shapes novel classes
By: Datamonitor
Introduction Datamonitor expects the Australian antidiabetics market to reach $416m by 2018. The growth will be driven by the launch of new drug classes, notably the incretin mimetics, and large growth in patient numbers. Although strongest  |  more...
10/20/2009       $5,700.00
Prescription Drug Wholesaling in the US - Industry Risk Rating Report
By: IBISWorld
Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Prescription Drug Wholesaling in the US industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of  |  more...
Search inside this report
10/17/2009       $825.00
Antidepressants Market Forecast
By: Datamonitor
Introduction With current blockbuster brands facing generic competition, Datamonitor forecasts the antidepressant market to decline at a compound annual growth rate of -2.0% (20082018). However, an antidepressant with a novel mechanism of action has huge commercial  |  more...
10/13/2009       $15,200.00
Snapshots France Pharmaceuticals 2009
By: Snapdata International Group
Snapdata's Snapshots France Pharmaceuticals 2009 provides 2007 year-end market size data, with 2008 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the French pharmaceutical market and  |  more...
Search inside this report
10/12/2009       $600.00
Snapshots Bulgaria Pharmaceuticals 2009
By: Snapdata International Group
Snapdata's Snapshots Bulgaria Pharmaceuticals 2009 provides 2007 year-end market size data, with 2008 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the Bulgarian pharmaceutical market and  |  more...
Search inside this report
10/12/2009       $600.00
Snapshots Australia Pharmaceuticals 2009
By: Snapdata International Group
Snapdata's Snapshots Australia Pharmaceuticals 2009 provides 2007 year-end market size data, with 2008 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the Australian pharmaceutical market and  |  more...
Search inside this report
10/12/2009       $600.00
The US Government's Financial Support to Push Comparative Effectiveness Research
By: GlobalData
Summary GlobalData's new report - "The US Government’s Financial Support to Push Comparative Effectiveness Research", explores the US medical equipment industry and the intricacies of the economic stimulus bill. The US Congress in the early part  |  more...
10/12/2009       $500.00
Privacy Policy    |    Terms and Conditions    |    Site Map    |    Return Policy    |    Press    |    Help FAQs
Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/22/2009 - 3